### **Data Enrichment: Better Targeting Through Complete Intelligence**

---

#### **Section 1: Hero Section**

*   **Headline:** Bridge the Data Gap for Better Targeting
*   **Sub-headline:** Transform incomplete data into complete patient insights for precise commercial execution
*   **Primary Call-to-Action (Button):** See How We Bridge the Gap

---

#### **Section 2: The Clinical Data Chasm**

##### **Better Targeting Starts Here**

*   **Intro Paragraph:** Claims data suffers with capture rate for key events like **Treatments, Mutations, Diagnosis, Lab Results** and other key events despite having good patient coverage. EHR data like **Tempus, Flatiron** has the coverage problem. We bridge the gap of patient coverage and event capture rate to help with your targeting. We specialise in **complex oncology** and **biopharmaceutical portfolios**.

---

##### **Illustration 1: The Data Coverage vs. Event Capture Matrix**

*   **Visual Description:** 
    *   **Type:** 2x2 Matrix Chart
    *   **X-Axis:** Patient Coverage (Low ‚Üí High)
    *   **Y-Axis:** Event Capture Rate (Low ‚Üí High)
    *   **Quadrants:**
        *   **Top Left (High Capture, Low Coverage):** EHR Data (Tempus, Flatiron) - Small circle, labeled "Rich Detail, Limited Reach"
        *   **Bottom Right (Low Capture, High Coverage):** Claims Data - Large circle, labeled "Broad Coverage, Missing Details"
        *   **Top Right (High Capture, High Coverage):** Enriched Data - Large star burst, labeled "Complete Intelligence - Our Solution"
        *   **Bottom Left:** Empty, labeled "Not Viable"
    *   **Annotations:** Arrows pointing from Claims + EHR toward the Enriched Data quadrant
    *   **Color Scheme:** Claims (blue), EHR (orange), Enriched (green/gold)

---

##### **The Claims Data Problem: Good Coverage, Poor Event Capture**

*   **Body Paragraph:** Claims data offers excellent patient coverage‚Äîtracking millions of patients across the healthcare system. However, it suffers with capture rate for the key clinical events that drive precision targeting decisions.

##### **Illustration 2: Claims Data - Coverage vs. Capture Comparison**

*   **Visual Description:**
    *   **Type:** Side-by-side horizontal bar chart
    *   **Left Bar:** "Patient Coverage" - 95% filled (green), labeled "Excellent: ~95% of patients captured"
    *   **Right Bar:** "Event Capture Rate" - 15% filled (red), labeled "Poor: ~15% of key events captured"
    *   **Gap Visualization:** Large red arrow or warning icon between bars with text "THE GAP"
    *   **Below Chart:** Icon grid showing 5 event types (Mutations, Treatments, Labs, Diagnosis, Other Events) - 1-2 out of 10 icons lit per row

*   **Missing Key Events:**
    *   üß¨ **Mutations:** Test orders visible, but results (PIK3CA, BRCA, EGFR) not captured
    *   üíä **Treatments:** Treatments prescribed, but outcomes and response not tracked
    *   üìä **Lab Results:** Lab tests ordered, but clinical values and biomarker outcomes missing
    *   üéØ **Diagnosis:** Disease codes present, but staging and progression unclear
    *   üìà **Other Key Events:** Treatment switches, progression events, adverse events poorly captured

##### **Illustration 3: Claims Data Event Capture Breakdown**

*   **Visual Description:**
    *   **Type:** Stacked horizontal bar chart with 5 rows
    *   **Rows (Events):** Mutations | Treatments | Lab Results | Diagnosis | Other Events
    *   **Each Bar:** Split into "Captured" (filled) vs "Missing" (empty/gray)
        *   Mutations: 12% captured (red), 88% missing (gray)
        *   Treatments: 25% captured (orange), 75% missing (gray)
        *   Lab Results: 10% captured (red), 90% missing (gray)
        *   Diagnosis: 30% captured (yellow), 70% missing (gray)
        *   Other Events: 18% captured (red), 82% missing (gray)
    *   **Title:** "What's Missing in Claims Data?"
    *   **Annotation:** Overall average: ~15-20% event capture rate

---

##### **The EHR Data Problem: Rich Detail, Limited Coverage**

*   **Body Paragraph:** EHR data like **Tempus, Flatiron** has the coverage problem‚Äîrich clinical detail but limited to select sites and practices, creating geographic and demographic blind spots.

##### **Illustration 4: EHR Data - Coverage vs. Capture Comparison**

*   **Visual Description:**
    *   **Type:** Side-by-side horizontal bar chart (mirror of Illustration 2)
    *   **Left Bar:** "Patient Coverage" - 10% filled (red), labeled "Limited: ~10% of patients captured"
    *   **Right Bar:** "Event Capture Rate" - 90% filled (green), labeled "Excellent: ~90% of key events captured"
    *   **Gap Visualization:** Large red arrow or warning icon between bars with text "THE GAP"
    *   **Below Chart:** Icon grid showing 5 event types - 9 out of 10 icons lit per row

*   **Coverage Limitations:**
    *   üè• **Limited Sites:** Only specific cancer centers and participating practices
    *   üìç **Geographic Gaps:** Major blind spots in coverage areas
    *   ‚è±Ô∏è **Data Freshness:** Delayed availability and slower refresh cycles
    *   üí∞ **High Cost:** Expensive per covered patient

##### **Illustration 5: EHR Data Event Capture Breakdown**

*   **Visual Description:**
    *   **Type:** Stacked horizontal bar chart with 5 rows (mirror of Illustration 3)
    *   **Rows (Events):** Mutations | Treatments | Lab Results | Diagnosis | Other Events
    *   **Each Bar:** Split into "Captured" (filled) vs "Missing" (empty/gray)
        *   Mutations: 92% captured (green), 8% missing (gray)
        *   Treatments: 88% captured (green), 12% missing (gray)
        *   Lab Results: 94% captured (green), 6% missing (gray)
        *   Diagnosis: 85% captured (green), 15% missing (gray)
        *   Other Events: 82% captured (green), 18% missing (gray)
    *   **Title:** "Rich Detail in EHR Data - But Limited Reach"
    *   **Annotation:** Overall average: ~85-90% event capture rate

---

##### **The Targeting Challenge: Two Incomplete Pictures**

##### **Illustration 6: Side-by-Side Comparison Summary**

*   **Visual Description:**
    *   **Type:** Comparison table with visual indicators
    *   **Layout:** Two columns (Claims Data | EHR Data) with 6 rows
    *   **Rows:**
        1. **Patient Coverage:** Large checkmark ‚úÖ | Red X ‚ùå
        2. **Event Capture:** Red X ‚ùå | Large checkmark ‚úÖ
        3. **Mutations Visible:** 12% (red gauge) | 92% (green gauge)
        4. **Treatments Captured:** 25% (orange gauge) | 88% (green gauge)
        5. **Lab Results:** 10% (red gauge) | 94% (green gauge)
        6. **Overall Targeting Capability:** ‚ö†Ô∏è Incomplete | ‚ö†Ô∏è Incomplete
    *   **Bottom Row (Spanning both columns):** 
        *   Large red banner: "Neither Source Alone Enables Effective Targeting"
        *   Sub-text: "Too broad (wasted resources) OR Too narrow (missed opportunities)"

*   **The Problem:** 
    *   **Claims Data:** You see millions of patients but can't identify the right ones to target
    *   **EHR Data:** You see rich clinical detail but only for a fraction of the market
    *   **Impact:** Either targeting too broadly (wasted resources) or too narrowly (missed opportunities)

---

##### **Our Solution: Bridging the Gap**

*   **Body Paragraph:** We bridge the gap of patient coverage and event capture rate to help with your targeting. Our AI-powered enrichment combines the breadth of claims coverage with the depth of EHR insights.

##### **Illustration 7: The Bridge - How We Create Complete Intelligence**

*   **Visual Description:**
    *   **Type:** Bridge/pathway illustration
    *   **Left Side:** Claims Data icon (database with "95% coverage" badge)
    *   **Right Side:** EHR Data icon (database with "90% event capture" badge)
    *   **Center:** Large bridge connecting both sides, labeled "AI-Powered Enrichment"
    *   **Bridge Elements (3 pillars):**
        1. **ML Models** - Predict missing events
        2. **Pattern Recognition** - Learn from EHR, apply to Claims
        3. **Validation** - Continuous accuracy improvement
    *   **Bottom/Destination:** Large platform labeled "Complete Intelligence: 95% Coverage √ó 85% Event Capture"
    *   **Annotations:** Arrows showing data flowing from both sources into the enrichment engine
    *   **Color Scheme:** Blue (Claims) + Orange (EHR) = Green/Gold (Enriched)

##### **Illustration 8: Before vs. After - The Targeting Transformation**

*   **Visual Description:**
    *   **Type:** Before/After scatter plot comparison
    *   **Layout:** Two side-by-side plots with same axes
    *   **Axes:** X = Patient Coverage (0-100%), Y = Event Capture Rate (0-100%)
    *   **Before (Left Plot):**
        *   Claims Data: Large blue circle at (95, 15) - labeled "Can't identify who to target"
        *   EHR Data: Small orange circle at (10, 90) - labeled "Only see fraction of market"
        *   Red diagonal line showing "Targeting Threshold" - neither point crosses it
        *   Shaded red zone: "Ineffective Targeting"
    *   **After (Right Plot):**
        *   Enriched Data: Large green star at (90, 85) - labeled "Precision Targeting Enabled"
        *   Green checkmark and shaded green zone: "Effective Targeting Zone"
        *   Annotation: "30x+ improvement in targetable population"
    *   **Arrow between plots:** "Our Enrichment Process"

*   **Our Specialty:**
    *   **üß¨ Complex Oncology:** Deep expertise in biomarker-driven cancer treatments where precision targeting is critical
    *   **üíä Biopharmaceutical Portfolios:** Purpose-built for the complex, multi-asset targeting challenges of modern pharma

---

#### **Section 3: Real-World Impact Examples**

*   **Headline:** Proven Results: How Enrichment Transforms Targeting Capability

*   **Example 1: Breast Cancer - PIK3CA & BRCA Markets**
    *   **Challenge:** Truqap (PIK3CA) and Lynparza (BRCA) require precise biomarker identification
    *   **Before Enrichment:** <1% of patients had identifiable biomarker status
    *   **After Enrichment:** ~35% PIK3CA identification, ~7% BRCA identification
    *   **Impact:** >30x increase in targetable patient population

*   **Example 2: Emerging Biomarker - HER2-Low**
    *   **Challenge:** Enhertu targets HER2-Low patients, but this biomarker had zero presence in claims
    *   **Before Enrichment:** 0% visibility into HER2-Low population
    *   **After Enrichment:** >50% identification of HER2-Low patients
    *   **Impact:** Created entire market view from scratch

*   **Example 3: Foundational Segments**
    *   **Challenge:** HR+ and HER2+ are critical breast cancer segments
    *   **Before Enrichment:** Low identification rates for key patient subtypes
    *   **After Enrichment:** ~90% HR+ identification, 4x improvement in HER2+ visibility
    *   **Impact:** Stronger foundation for portfolio strategies

*   **Visual Element:** [Before/After bar charts showing the dramatic increase in patient identification across these examples]

---

#### **Section 4: The Ultimate Value: Complete Intelligence Enables Commercial Excellence**

*   **Headline:** Enriched Data Powers Your Entire Commercial Strategy

*   **Body Paragraph:** This comprehensive patient intelligence enables precision across every aspect of your commercial execution:

*   **Strategic Capabilities:**
    1.  **üéØ Accurate Market Sizing:** Understand the true, addressable patient opportunity for every indication
    2.  **üë®‚Äç‚öïÔ∏è Precision HCP Targeting:** Identify oncologists treating the exact patient subtypes relevant to each brand
    3.  **üìä Sophisticated Segmentation:** Enable patient-level segmentation for advanced targeting strategies
    4.  **üîÑ Next-Best-Action Models:** Power intelligent orchestration and engagement sequencing

*   **Business Impact:**
    *   **Better Resource Allocation:** Focus investments on the right patients and physicians
    *   **Improved Market Share:** Target missed opportunities with precise segmentation
    *   **Portfolio Optimization:** Unlock multi-asset strategies with complete patient views
    *   **Competitive Advantage:** See what others can't with comprehensive data intelligence

*   **Looking Ahead:** This high-fidelity patient map solves the *identification* problem and becomes the foundation for **Intelligent Orchestration**‚Äîknowing precisely what to communicate, and in what order, for every HCP interaction.

---

#### **Section 5: Final Call to Action**

*   **Headline:** Ready to Bridge the Data Gap?

*   **Body Paragraph:** Stop making targeting decisions with incomplete data. See how we combine the breadth of claims coverage with the depth of EHR insights to create complete patient intelligence for your commercial strategy.

*   **Primary Call-to-Action (Button):** Schedule a Demo
*   **Secondary CTA:** Request a Sample Enrichment Report